# Danaher to acquire Masimo Corporation for $9.9 billion

Danaher Corporation announced a definitive agreement to acquire Masimo Corporation for $180 per share in cash, with a total enterprise value of approximately $9.9 billion. Masimo, a provider of pulse oximetry and patient monitoring solutions, will become a standalone operating company within Danaher's Diagnostics segment.

- Type: Acquisition
- Announced: 2026-02-17
- Where: United States
- Value: $9.90B
- Status: announced
- Products: pulse oximetry, patient monitoring solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Danaher](https://endata.com/companies/16260.md) (acquirer)
- [Masimo](https://endata.com/companies/16261.md) (target)

## Sources

- [investors.danaher.com](https://investors.danaher.com/2026-02-17-Danaher-To-Acquire-Masimo-Corporation), 2026-02-17: "We are excited to welcome the Masimo team to Danaher."
- [medtechdive.com](https://www.medtechdive.com/news/danaher-to-buy-masimo-for-99b-to-boost-diagnostics-portfolio/812320/), 2026-02-17: "Masimo's advanced sensor technology and AI-enabled monitoring bring powerful new capabilities to our diagnostics portfolio."
- [news.bloomberglaw.com](https://news.bloomberglaw.com/mergers-and-acquisitions/danaher-agrees-to-buy-medical-tech-firm-masimo-for-9-9-billion), 2026-02-17: "Danaher Corp. agreed to buy Masimo Corp., in a deal with an enterprise value of about $9.9 billion."
- [thehealthcaretechnologyreport.com](https://thehealthcaretechnologyreport.com/danaher-announces-acquisition-of-masimo-corporation-in-9-9b-diagnostics-deal/), 2026-03-09: "With the Danaher Business System and our global scale, we see opportunities to expand Masimo’s reach and continue improving outcomes for patients, particularly those in acute care settings."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.